A Softer Strategy for Drug-Resistant Hypertension
Severe high blood pressure remains stubbornly difficult to control for many patients, even with combinations of three to five medications. For about one in ten people with hypertension, this “drug-resistant” form keeps blood pressure at dangerous levels despite aggressive therapy. Researchers at Penn State’s College of Engineering are exploring a radically different high blood pressure treatment: soft 3D printed implants that work with the body’s own pressure-regulation system rather than against it. Their tiny cardiovascular implants, dubbed CaroFlex, wrap around arteries and deliver targeted electrical stimulation to the nerves that govern the baroreflex—the body’s built-in pressure sensor. Instead of adding yet another pill, this approach uses bioelectronic signals to nudge cardiovascular control circuits directly. Early experiments in rodents suggest the flexible medical devices can reduce hypertension while causing less damage to surrounding tissue than traditional, rigid hardware.
How CaroFlex Works With the Body’s Natural Pressure Sensor
CaroFlex is a fingertip-sized, soft bioelectronic device designed to attach to the carotid sinus, a key region near the carotid artery that helps regulate blood pressure. The carotid sinus is packed with specialized nerve endings that monitor how much the artery wall stretches as blood pulses through. When blood pressure rises, these sensors trigger the baroreflex, signaling the nervous system to lower pressure. Prior cardiovascular implants tried to electrically stimulate this system but relied on rigid components that could irritate tissue or lose effectiveness over time. CaroFlex takes a different path, using stretchable materials that bend and move with each heartbeat. By closely matching the artery’s motion, the 3D printed implant can deliver consistent electrical stimulation while minimizing friction and mechanical stress. In rodent studies, varying stimulation frequencies using CaroFlex led to reductions in systolic, diastolic, and mean arterial pressure, highlighting its potential as a new high blood pressure treatment tool.
3D Printing and Hydrogels Enable Flexible, Suture-Free Implants
The technical leap behind CaroFlex lies in combining flexible materials with advanced 3D printing. Traditional fabrication struggles to make electronics that are both soft and precisely shaped for delicate anatomy. Penn State’s team instead uses syringe-like extrusion printers to deposit soft, conductive inks layer by layer, building custom-shaped cardiovascular implants that can stretch and twist with arteries. To avoid sutures—which can damage moving vessels over time—the researchers added a soft adhesive hydrogel layer that gently sticks to the artery’s surface. This suture-free design reduces mechanical irritation while still requiring surgery for placement in its current form. The result is a new class of flexible medical devices that sit more like a second skin than a rigid foreign object. For patients, that could translate into less inflammation, fewer complications, and better long-term performance compared with conventional, hard bioelectronic implants.
Part of a Broader Shift Toward Soft Bioelectronics
CaroFlex reflects a broader push in healthcare toward soft bioelectronics and personalized cardiovascular implants. Tao Zhou’s lab, which leads the project, has already demonstrated 3D printed brain sensors built from hydrogel-based materials that conform precisely to the brain’s folds, as well as honeycomb-inspired electrodes that stretch without losing strength or sensitivity. Across medicine, researchers are exploring flexible electronics for smart bandages, skin-like wearables, neural interfaces, and soft robotics. 3D printing plays a central role, enabling intricate geometries and tailored mechanical properties that traditional manufacturing rarely achieves. Still, the path from lab prototype to clinical device is long. CaroFlex has so far only been tested in animals, and key hurdles remain: long-term durability, scaling up production, and rigorous safety and regulatory evaluations. Even so, the project underscores how 3D printed implants could reshape high blood pressure treatment by making bioelectronic therapies gentler, more adaptable, and closer in behavior to living tissue.